Results 271 to 280 of about 5,922,427 (309)

Stem Cell Transplantation Methods

2010
Just a few short years ago, we still used to think that we were born with a finite number of irreplaceable neurons. However, in recent years, there has been increasingly persuasive evidence that suggests that neural stem cell (NSC) maintenance and differentiation continue to take ace throughout the mammal's lifetime.
Kimberly D, Tran, Allen, Ho, Rahul, Jandial   +2 more
openaire   +2 more sources

Cytokines in Stem Cell Transplantation

Annals of the New York Academy of Sciences, 1995
The use of cytokines in stem cell transplantation is still in the early stages of development. Efficacy has not been established consistently at the present time. When cytokines are employed in the treatment setting, they should be employed in a study setting evaluating whether there has been real patient benefit-palliation without compromise of ...
openaire   +2 more sources

Stem Cell Transplants at Childbirth

Stem Cell Reviews and Reports, 2009
Autologous transplantation of stem cells is a natural phenomenon at birth in mammals via the umbilical cord. Here, we discuss that a delay in the cord clamping may increase stem cell supply to the baby, thereby allowing an innate stem cell therapy that can render acute benefits in the case of neonatal disease, as well as long-term benefits against age ...
Paul R, Sanberg, Dong-Hyuk, Park, Cesar V, Borlongan   +2 more
openaire   +2 more sources

Stem cell transplantation for thalassaemia

Reproductive BioMedicine Online, 2005
Although improvements in conventional treatment have enhanced the prognosis of thalassaemia, stem cell transplantation remains the only cure. Over the last 2 decades, progress in preventive strategies, effective control of transplant related complications and development of new preparative regimens, have considerably improved the results of transplants
Javid, Gaziev, Guido, Lucarelli
openaire   +2 more sources

Hematopoietic Stem Cell Transplantation

Hospital Practice, 1993
The isolation, purification, and in vitro expansion of the hematopoietic stem cell have allowed pretransplant immunologic and genetic manipulation. As a result, rapid allogeneic or autologous hematologic reconstitution with minimal graft-versus-host disease is possible in patients receiving high-dose chemotherapy.
S, Jagannath, B, Barlogie, G, Tricot
openaire   +2 more sources

Spermatogonial stem cell transplantation

Molecular and Cellular Endocrinology, 2000
The development of the spermatogonial transplantation technique has given new impetus to research on spermatogonial stem cells. Possibilities opened by this technique include: (a) New ways to study fundamental aspects of spermatogenesis; (b) Generation of transgenic large domestic animals; (c) Protection of (young) male cancer patients from infertility
Izadyar, F., Creemers, L. B., van Dissel-Emiliani, F. M., van Pelt, A. M., de rooij, D. G.   +4 more
openaire   +3 more sources

Stem cell transplantation for thalassemia

International Journal of Hematology, 2002
Thalassemia, one of the most common genetic disorders, is considered to be a global problem. Several millions of the patients suffer from severe thalassemic diseases. Stem cell transplantation is currently the only curative therapy. Bone marrow transplantation offers a high probability of cure when performed in young children. There is a higher risk as
openaire   +2 more sources

Hematopoietic Stem-Cell Transplantation

New England Journal of Medicine, 2006
Hematopoietic stem-cell transplantation, which is used to treat both malignant and nonmalignant conditions, was first conceived more than 50 years ago, but problems associated with transplanting a nonsolid organ and modulating the immune response had to be solved before the procedure could be used clinically.
openaire   +2 more sources

Neural Transplantation and Stem Cells

2009
Recent results have raised important questions on our ability to amplify stem cell populations in sufficient numbers as to be useful for therapy. Several reports have indicated that human stem cell populations harvested from the adult have low or undetectable telomerase levels, age in culture, and may not be propagated indefinitely.
Mahendra S, Rao, Mohan C, Vemuri
openaire   +2 more sources

In utero stem cell transplantation

Best Practice & Research Clinical Obstetrics & Gynaecology, 2004
In utero haematopoietic cell transplantation (IUHCT) is a promising approach for the treatment of a variety of genetic disorders. The rationale is to take advantage of normal events during haematopoietic and immunological ontogeny to facilitate allogeneic haematopoietic engraftment.
openaire   +2 more sources